Why the study?
This study evaluated the delivery of Strong Hearts, Healthy Communities 2.0 (SHHC-2.0) to prepare the cardiovascular disease prevention intervention for further dissemination.
Does the SHHC-2.0 cardiovascular disease prevention program achieve high implementation fidelity and participant satisfaction in rural women?
Does the SHHC-2.0 cardiovascular disease prevention program achieve high implementation fidelity and participant satisfaction in rural women?
The SHHC-2.0 cardiovascular disease prevention program demonstrated high fidelity, dose delivery, and participant satisfaction, supporting its feasibility and dissemination in rural communities.
Feasible rural CVD prevention delivery with high fidelity and satisfaction; leaves open strategies to improve reach and long-term adherence.
BACKGROUND: Strong Hearts, Healthy Communities 2.0 (SHHC-2.0) was a 24-week cardiovascular disease prevention program that was effective in improving physical activity and nutrition behaviors and clinical outcomes among women in 11 rural New York, USA towns. This study evaluated the delivery of SHHC-2.0 to prepare the intervention for further dissemination. METHODS: This process evaluation was guided by the Medical Research Council recommendations and engaged program leaders and participants (i.e., women over age 40) using quantitative and qualitative methods. The quantitative evaluation included examination of enrollment and retention data, a participant survey, and a fidelity checklist completed after classes. Descriptive and comparative statistics were used to assess implementation measures: program reach, participant attendance, dose delivered, program length, perceived effectiveness, fidelity, and participant satisfaction. The qualitative evaluation included focus groups (n = 13) and interviews (n = 4) using semi-structured guides; audio was recorded and transcripts were deductively coded and analyzed using directed content analysis and iterative categorization approaches. Comparisons across towns and between intervention and waitlist control groups were explored. RESULTS: Average reach within towns was 7.5% of the eligible population (range 0.7-15.7%). Average attendance was 59.8% of sessions (range 42.0-77.4%). Average dose delivered by leaders was 86.4% of curriculum components (range 73.5-95.2%). Average session length was 51.8 ± 4.8 min across 48 sessions. Leaders' perceived effectiveness rating averaged 4.1 ± 0.3 out of 5. Fidelity to curricular components was 81.8% (range 67.4-93.2%). Participants reported being "more than satisfied" with the overall program (88.8%) and the health benefits they obtained (72.9%). Qualitative analysis revealed that participants: (1) gained new knowledge and enjoyable experiences; (2) perceived improvements in their physical activity, nutrition, and/or health; (3) continued to face some barriers to physical activity and healthy eating, with those relating to social support being reduced; and (4) rated leaders and the group structure highly, with mixed opinions on the research elements. CONCLUSIONS: SHHC-2.0 had broad reach, was largely delivered as intended, and participants expressed high levels of satisfaction with the program and its health benefits. Our findings expand on best practices for implementing cardiovascular disease prevention programs in rural communities. CLINICAL TRIALS REGISTRATION: www. CLINICALTRIALS: gov #NCT03059472.
No takes yet. Share an insight, caveat, or question.
Szeszulski et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: